Aphria Inc.

NASDAQ: APHA
$4.38
+$0.08 (+1.9%)
Closing price July 6, 2020
Aphria, an analyst favorite among pot stocks, rallies after market selloff Thursday.
Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability. In the United States, high state and...
Aurora Cannabis closed its acquisition of Reliva ahead of schedule but poor results from Canopy Growth may have dinged pot stocks.
Beginning June 8, Canadian marijuana company Aphria will switch from the NYSE to the Nasdaq exchange, with the same symbol.
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.
Aphria stays strong while Green Growth, which tried to buy it, goes bust. Canadian rival Aurora buys U.S. hemp retailer Reliva.
Canadian pot company Aphria is well positioned in the medical and recreational sectors. It has eyes on Europe but the coronavirus has stalled legalization efforts in the U.S.
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Here's a look at what has caused Canada's marijuana sales to increase so slowly, what impact that had on Aphria in particular, and how the pandemic will affect that company's future.
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
In pandemic times, solid balance sheets have been a beacon of hope to investors, and for those wishing to get into the cannabis industry, a cash-rich company like Aphria may be that vehicle.
The entire Canadian pot industry is in wait-and-see mode due to the pandemic, both the companies and investors. However, it will not remain that way forever. Is Aphria growing stronger as the...
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Something is moving Tilray stock far higher than other pot stocks. What can account for a 67% one-day jump in the cannabis company's share price?
After brutal sell-offs during the past year, some of the cannabis stocks have bounced back, a relief for many investors. Is Aphria set to be a winner?